CBO finds Senate's FDA user fee bill will reduce the federal deficit by about $1.4B
As debate rages on Capitol Hill over whether to add riders, and which riders to add, to the must-pass FDA user fee legislation, the Congressional Budget Office on Thursday made clear that the Senate version will reduce the federal deficit by about $1.4 billion over the next 10 years.
Congress has until the end of September to reauthorize the user fees, which the FDA collects for its review of prescription drugs, generics, biosimilars and medical devices.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
